Sufficient Treatment of Peripheral Intervention by Cilostazol

NCT00912756 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

200

Enrollment

OTHER

Sponsor class

Conditions

Arteriosclerosis Obliterans

Interventions

DRUG: cilostazol

Sponsor

Kansai Rosai Hospital

Collaborators

[object Object]